Management of retinopathy of prematurity (ROP) in a Polish cohort of infants

Abstract Retinopathy of prematurity (ROP) is potentially blinding, but screening and timely treatment can stop its progression. The data on treatment outcomes of ROP from Central and Eastern Europe are scarce. Therefore, we aimed to analyze the latest results of ROP management in Poznan medical cent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna Chmielarz-Czarnocińska, Marta Pawlak, Dawid Szpecht, Aneta Choręziak, Marta Szymankiewicz-Bręborowicz, Anna Gotz-Więckowska
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/16ba8bd952cf4b7783265b8b06ce8a41
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:16ba8bd952cf4b7783265b8b06ce8a41
record_format dspace
spelling oai:doaj.org-article:16ba8bd952cf4b7783265b8b06ce8a412021-12-02T13:20:12ZManagement of retinopathy of prematurity (ROP) in a Polish cohort of infants10.1038/s41598-021-83985-52045-2322https://doaj.org/article/16ba8bd952cf4b7783265b8b06ce8a412021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83985-5https://doaj.org/toc/2045-2322Abstract Retinopathy of prematurity (ROP) is potentially blinding, but screening and timely treatment can stop its progression. The data on treatment outcomes of ROP from Central and Eastern Europe are scarce. Therefore, we aimed to analyze the latest results of ROP management in Poznan medical center to update the data from this world region. In the years 2016–2019, 178 patients (350 eyes) received treatment for ROP (6.1% of the screened population). The mean gestational age was 26 weeks (range 22–31 weeks), the mean birth weight was 868 g (range 410–1890 g). The most frequent ROP stage at treatment was zone II, stage 3 + (34.9%). As the first line of treatment, 115 infants (226 eyes, 64.6%) underwent laser photocoagulation (LP); 61 infants (120 eyes, 34.3%) received intravitreal ranibizumab injections (IVR); and 2 infants (4 eyes, 0.6%) were treated simultaneously with LP and IVR. One hundred twenty-six eyes (36%) of 63 patients required retreatment: 20.4% treated with LP and 66.7% treated with IVR. Retinal detachment occurred in 14 eyes (4%). The incidence of ROP, ROP requiring treatment, and reoccurrence rates are higher in the Polish population than in Western Europe and the USA. The identified treatment patterns find increasing use of anti-VEGF agents.Anna Chmielarz-CzarnocińskaMarta PawlakDawid SzpechtAneta ChoręziakMarta Szymankiewicz-BręborowiczAnna Gotz-WięckowskaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Anna Chmielarz-Czarnocińska
Marta Pawlak
Dawid Szpecht
Aneta Choręziak
Marta Szymankiewicz-Bręborowicz
Anna Gotz-Więckowska
Management of retinopathy of prematurity (ROP) in a Polish cohort of infants
description Abstract Retinopathy of prematurity (ROP) is potentially blinding, but screening and timely treatment can stop its progression. The data on treatment outcomes of ROP from Central and Eastern Europe are scarce. Therefore, we aimed to analyze the latest results of ROP management in Poznan medical center to update the data from this world region. In the years 2016–2019, 178 patients (350 eyes) received treatment for ROP (6.1% of the screened population). The mean gestational age was 26 weeks (range 22–31 weeks), the mean birth weight was 868 g (range 410–1890 g). The most frequent ROP stage at treatment was zone II, stage 3 + (34.9%). As the first line of treatment, 115 infants (226 eyes, 64.6%) underwent laser photocoagulation (LP); 61 infants (120 eyes, 34.3%) received intravitreal ranibizumab injections (IVR); and 2 infants (4 eyes, 0.6%) were treated simultaneously with LP and IVR. One hundred twenty-six eyes (36%) of 63 patients required retreatment: 20.4% treated with LP and 66.7% treated with IVR. Retinal detachment occurred in 14 eyes (4%). The incidence of ROP, ROP requiring treatment, and reoccurrence rates are higher in the Polish population than in Western Europe and the USA. The identified treatment patterns find increasing use of anti-VEGF agents.
format article
author Anna Chmielarz-Czarnocińska
Marta Pawlak
Dawid Szpecht
Aneta Choręziak
Marta Szymankiewicz-Bręborowicz
Anna Gotz-Więckowska
author_facet Anna Chmielarz-Czarnocińska
Marta Pawlak
Dawid Szpecht
Aneta Choręziak
Marta Szymankiewicz-Bręborowicz
Anna Gotz-Więckowska
author_sort Anna Chmielarz-Czarnocińska
title Management of retinopathy of prematurity (ROP) in a Polish cohort of infants
title_short Management of retinopathy of prematurity (ROP) in a Polish cohort of infants
title_full Management of retinopathy of prematurity (ROP) in a Polish cohort of infants
title_fullStr Management of retinopathy of prematurity (ROP) in a Polish cohort of infants
title_full_unstemmed Management of retinopathy of prematurity (ROP) in a Polish cohort of infants
title_sort management of retinopathy of prematurity (rop) in a polish cohort of infants
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/16ba8bd952cf4b7783265b8b06ce8a41
work_keys_str_mv AT annachmielarzczarnocinska managementofretinopathyofprematurityropinapolishcohortofinfants
AT martapawlak managementofretinopathyofprematurityropinapolishcohortofinfants
AT dawidszpecht managementofretinopathyofprematurityropinapolishcohortofinfants
AT anetachoreziak managementofretinopathyofprematurityropinapolishcohortofinfants
AT martaszymankiewiczbreborowicz managementofretinopathyofprematurityropinapolishcohortofinfants
AT annagotzwieckowska managementofretinopathyofprematurityropinapolishcohortofinfants
_version_ 1718393195228823552